OTCMKTS:WUXIF WuXi AppTec (WUXIF) Stock Price, News & Analysis → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free WUXIF Stock Alerts $4.70 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$4.70▼$4.7050-Day Range$4.35▼$6.8252-Week Range$4.35▼$12.69VolumeN/AAverage Volume831 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get WuXi AppTec alerts: Email Address Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. About WuXi AppTec Stock (OTCMKTS:WUXIF)WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.Read More WUXIF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WUXIF Stock News HeadlinesMay 15, 2024 | msn.comUS House committee moves quickly to approve bill limiting business with Chinese biotech firmsMay 15, 2024 | bizjournals.comChina-connected South Bay biotech company called out by Congress in Biosecure ActMay 15, 2024 | msn.comUS House committee advances bill to restrict BGI, WuXi AppTecMay 15, 2024 | msn.comUS House committee voices support for bill to restrict BGI, WuXi AppTecMay 15, 2024 | reuters.comUS House committee to vote on bill to restrict BGI, WuXi AppTecMay 14, 2024 | bloomberg.comWuXi Says Parent Owned a DNA Pioneer But It Never Accessed DataMay 11, 2024 | americanbankingnews.comWuXi AppTec Co., Ltd. (OTCMKTS:WUXIF) Sees Significant Increase in Short InterestMay 10, 2024 | finance.yahoo.comUS to announce new $400 mln military aid package for Ukraine, official saysMay 10, 2024 | msn.comUS bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut tiesMay 10, 2024 | reuters.comU.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut tiesApril 30, 2024 | markets.businessinsider.comHere's what to expect from WuXi AppTec's earnings reportApril 29, 2024 | finance.yahoo.comWuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable OperationsApril 25, 2024 | ft.comBristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharmaApril 17, 2024 | forbes.comInnovationRx: Legislation Could Prevent Pharma Companies From Working With Chinese ContractorsApril 15, 2024 | msn.comResearch for Sale: How Chinese Money Flows to American UniversitiesMarch 28, 2024 | reuters.comExclusive: China's WuXi AppTec shared US client's data with Beijing, US intelligence officials told senatorsMarch 25, 2024 | msn.comChina's WuXi AppTec In Crosshairs of US Draft Biosecurity BillMarch 19, 2024 | marketwatch.comWuXi AppTec's Shares Fall After Downbeat GuidanceMarch 19, 2024 | ft.comWuXi AppTec lobbies against US bill that aims to restrict Chinese pharma groupsMarch 18, 2024 | msn.comWuXi AppTec’s Net Profit Jumps, Reiterates It Doesn’t Pose Security ThreatMarch 18, 2024 | finance.yahoo.comWuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First TimeMarch 15, 2024 | finance.yahoo.comBIO Backflips on US Bill Limiting China Ties as WuXi ExitsMarch 14, 2024 | msn.comWuXi Shares Fall as Washington Lobbying Group Cuts TiesMarch 8, 2024 | uk.finance.yahoo.comTime to 'cut off' US outbound investment in China biotech firms like BGI Group and Wuxi AppTec: House panelMarch 6, 2024 | yahoo.comWuXi AppTec, WuXi Bio Tumble After US Panel Advances Ban BillSee More Headlines Receive WUXIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:WUXIF CUSIPN/A CIKN/A Webwww.wuxiapptec.com Phone86-21-5046-1111FaxN/AEmployees41,116Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Ge Li Ph.D. (Age 57)Co-Founder, Chairman, President & CEO Dr. Minzhang Chen Ph.D. (Age 55)Co-CEO & Executive Director Dr. Qing Yang Ph.D. (Age 55)Co-CEO & Executive Director Dr. Edward Hu M.B.A. (Age 62)Vice Chairman of the Board & Global Chief Investment Officer Ms. Ming Shi (Age 50)Senior VP & CFO Mr. Zhaohui Zhang (Age 55)COO of China, VP & Executive Director Mr. Yuanzhou Zhang (Age 36)Joint Company Secretary Mr. Ruijia TangIR DirectorDr. Howard Wu J.D.Senior VP, General Counsel & Global Head of Human ResourcesDr. Jingchao Dong Ph.D.Senior VP & Head of RCSMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors WUXIF Stock Analysis - Frequently Asked Questions How have WUXIF shares performed in 2024? WuXi AppTec's stock was trading at $9.9301 at the beginning of the year. Since then, WUXIF shares have decreased by 52.7% and is now trading at $4.70. View the best growth stocks for 2024 here. Are investors shorting WuXi AppTec? WuXi AppTec saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 606,000 shares, an increase of 121.7% from the April 15th total of 273,300 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days. View WuXi AppTec's Short Interest. What ETFs hold WuXi AppTec's stock? ETFs with the largest weight of WuXi AppTec (OTCMKTS:WUXIF) stock in their portfolio include First Trust Indxx Medical Devices ETF (MDEV).KraneShares MSCI All China Health Care Index ETF (KURE). How do I buy shares of WuXi AppTec? Shares of WUXIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:WUXIF) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi AppTec Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.